BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24841977)

  • 21. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.
    Wunder JS; Paulian G; Huvos AG; Heller G; Meyers PA; Healey JH
    J Bone Joint Surg Am; 1998 Jul; 80(7):1020-33. PubMed ID: 9698007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
    Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience.
    McLean TW; Hertel C; Young ML; Marcus K; Schizer MA; Gebhardt M; Weinstein HJ; Perez-Atayde A; Grier HE
    J Pediatr Hematol Oncol; 1999; 21(6):486-93. PubMed ID: 10598659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution's Experience Over 40 Years.
    Kharod SM; Spiguel AR; Lagmay JP; Jones C; Morris CG; Gibbs CP; Zlotecki RA
    Am J Clin Oncol; 2019 May; 42(5):421-425. PubMed ID: 30883389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007.
    Schrager J; Patzer RE; Mink PJ; Ward KC; Goodman M
    J Registry Manag; 2011; 38(3):153-61. PubMed ID: 22223058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative Electron-Beam Radiation Therapy for Pediatric Ewing Sarcomas and Rhabdomyosarcomas: Long-Term Outcomes.
    Sole CV; Calvo FA; Polo A; Cambeiro M; Gonzalez C; Desco M; Martinez-Monge R
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1069-1076. PubMed ID: 26194682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time to diagnosis of ewing tumors in children and adolescents is not associated with metastasis or survival.
    Alonso L; Navarro-Perez V; Sanchez-Muñoz A; Alba E
    J Clin Oncol; 2014 Dec; 32(35):4020. PubMed ID: 25385742
    [No Abstract]   [Full Text] [Related]  

  • 28. Metastatic Ewing sarcoma/PNET of bone at diagnosis: prognostic factors--a report from Saudi Arabia.
    Jenkin RD; Al-Fawaz I; Al-Shabanah MO; Allam A; Ayas M; Memon M; Rifai S; Schultz HP
    Med Pediatr Oncol; 2001 Oct; 37(4):383-9. PubMed ID: 11568903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric Ewing sarcoma of the head and neck: A retrospective survival analysis.
    Martin E; Radomski S; Harley EH
    Int J Pediatr Otorhinolaryngol; 2019 Feb; 117():138-142. PubMed ID: 30579068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
    Lee JA; Kim DH; Cho J; Lim JS; Koh JS; Yoo JY; Kim MS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
    Jpn J Clin Oncol; 2011 Jun; 41(6):776-82. PubMed ID: 21415003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma.
    Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K
    Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pediatric Ewing sarcoma of the rib: role of neoadjuvant chemotherapy in tumoral shrinking and sterilization. A case report].
    Zidane A; Traibi A; Arsalane A; Atoini F; Ouriachi F; Hammoumi M; Kabiri EH
    Rev Pneumol Clin; 2011 Dec; 67(6):371-4. PubMed ID: 22137283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy.
    Shamberger RC; LaQuaglia MP; Gebhardt MC; Neff JR; Tarbell NJ; Marcus KC; Sailer SL; Womer RB; Miser JS; Dickman PS; Perlman EJ; Devidas M; Linda SB; Krailo MD; Grier HE; Granowetter L
    Ann Surg; 2003 Oct; 238(4):563-7; discussion 567-8. PubMed ID: 14530727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual form and location for a tumor: multiosseous Ewing sarcoma in the foot.
    Jamshidi K; Shiradi MR
    Am J Orthop (Belle Mead NJ); 2015 Jan; 44(1):E32-5. PubMed ID: 25566563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.
    Brown TR; Vijarnsorn C; Potts J; Milner R; Sandor GG; Fryer C
    Pediatr Blood Cancer; 2013 May; 60(5):842-8. PubMed ID: 23382019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.
    Friedman DN; Chastain K; Chou JF; Moskowitz CS; Adsuar R; Wexler LH; Chou AJ; DeRosa A; Candela J; Magnan H; Pun S; Kahan T; Wolden SL; Meyers PA; Oeffinger KC
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local control and sequelae in localised Ewing tumours of the spine: a French retrospective study.
    Vogin G; Helfre S; Glorion C; Mosseri V; Mascard E; Oberlin O; Gaspar N
    Eur J Cancer; 2013 Apr; 49(6):1314-23. PubMed ID: 23402991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-relapse survival in patients with Ewing sarcoma.
    Ferrari S; Luksch R; Hall KS; Fagioli F; Prete A; Tamburini A; Tienghi A; DiGirolamo S; Paioli A; Abate ME; Podda M; Cammelli S; Eriksson M; Brach del Prever A
    Pediatr Blood Cancer; 2015 Jun; 62(6):994-9. PubMed ID: 25585917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ewing Sarcoma: A 15-Year Experience of a Single Center With the MSKCC P6 Treatment Protocol.
    Ben-Ami T; Waldman E; Marc W; Weintraub M; Revel-Vilk S; Fried I
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):38-42. PubMed ID: 26670840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors.
    Tap WD; Demetri G; Barnette P; Desai J; Kavan P; Tozer R; Benedetto PW; Friberg G; Deng H; McCaffery I; Leitch I; Badola S; Chang S; Zhu M; Tolcher A
    J Clin Oncol; 2012 May; 30(15):1849-56. PubMed ID: 22508822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.